HemaSphere (Jun 2022)

P536: VALUE OF MEASURABLE RESIDUAL DISEASE BY MULTIPARAMETRIC FLOW CYTOMETRY IN NON-PROMYELOCYTIC ACUTE MYELOID LEUKEMIA. REAL WORLD EVIDENCE

  • A. D. Gimenez Conca,
  • J. Gonzalez,
  • M. M. Rivas,
  • A. Navickas,
  • I. Fernandez,
  • I. Rey,
  • H. Dick,
  • S. Cranco,
  • M. Moirano,
  • L. Ferrari,
  • M. Clavijo,
  • A. Suero,
  • R. Ramirez,
  • A. L. Basquiera,
  • N. Carnelutto,
  • M. L. Rapan,
  • A. Jorge Alberto,
  • C. Belli

DOI
https://doi.org/10.1097/01.HS9.0000845032.88331.93
Journal volume & issue
Vol. 6
pp. 435 – 436

Abstract

Read online

No abstracts available.